Fierce Pharma

DECEMBER 14, 2023

Pfizer’s $43 billion acquisition of Seagen is in the books, the company said on Thursda | It’s a done deal. Pfizer’s $43 billion acquisition of Seagen is in the books, as it becomes the largest M&A transaction in the biopharma industry since AbbVie snatched up Allergan for $63 billion in 2019. The buyout of the antibody-drug conjugate specialist has doubled Pfizer’s pipeline to 60 programs.

Biopharma 363

Biopharma 363

MedCity News

DECEMBER 14, 2023

There are a lack of women at venture capital firms. This makes it difficult for women’s health startups focused on stigmatized conditions to get funding when pitching to those who don’t always have a good understanding, startups say.

131

131

Fierce Pharma

DECEMBER 14, 2023

Despite the high list price of Lyfgenia, bluebird has signed a large reimbursement deal for the sickle cell disease (SCD) gene therapy less than a week after its

319

319

MedCity News

DECEMBER 14, 2023

Atropos Health and Seqster joined forces to address historical diversity and inclusion challenges in clinical trials. The partnership seeks to enable the swift creation of turnkey patient registries that generate real world evidence from existing registries in under 48 hours.

Patients 123

Patients Biopharma 123

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 14, 2023

While existing neuroblastoma treatments can help patients achieve remission, sustaining that remission has proven tricky. But now, patients and doctors have a new oral option. | The U.S. FDA has approved US WorldMeds’ Iwilfin—also known as eflornithine—as a new oral maintenance therapy for high-risk neuroblastoma. The drug, cleared in 192 mg tablets, is indicated to cut the risk of relapse in kids and adults with high-risk neuroblastoma who’ve had at least a partial response to prior treatment.

FDA 279

FDA Doctors Patients 279

PharmaTimes

DECEMBER 14, 2023

The collaboration aims to develop biomarker-based diagnostics for the condition - News - PharmaTimes

120

120

European Pharmaceutical Review

DECEMBER 14, 2023

In the ever-evolving landscape of regulatory decisions, the quest for safeguarding public health remains paramount. Decisions to remove medicines from market are not taken lightly and are often based upon all evidence available to inform a benefit/risk balance. This evidence can come from a range of sources, such as randomised controlled trials (RCTs), observational studies, and spontaneous reporting.

Medicine 116

Medicine Safety Competition Medical 116

Fierce Pharma

DECEMBER 14, 2023

Bristol Myers Squibb inked an antibody-drug conjugate (ADC) licensing deal worth up to $8.4 billion. AstraZeneca and Gilead's ADCs passed on China's national insurance scheme. | Bristol Myers Squibb inked an antibody-drug conjugate (ADC) licensing deal worth up to $8.4 billion. AstraZeneca and Gilead's ADCs passed on China's national insurance scheme.

Insurance 130

Insurance Pharma FDA 130

MedCity News

DECEMBER 14, 2023

Sales performance management (SPM) solutions, also known as distribution management systems, continue to be a competitive differentiator and vital to insurers’ top and bottom lines.

Insurance 115

Insurance Competition Management Sales 115

pharmaphorum

DECEMBER 14, 2023

White House says 48 drugs are heading for Medicare rebates Phil.

111

111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

DECEMBER 14, 2023

The mandates set the framework and data requirements for transparency but consumers need more guidance for informed decision-making and comparisons. Health plans should be acting now to turn the conversation from compliance to true member engagement.

115

115

PharmaTimes

DECEMBER 14, 2023

The free programme will be offered to those who are affected by the condition - News - PharmaTimes

111

111

MedCity News

DECEMBER 14, 2023

The notion that patients are always better off receiving treatment at academic centers is flawed, and when an employer offers a COE approach, it can mislead patients to choose that option when care in their local community may be more sensible.

Patients 115

Patients 115

pharmaphorum

DECEMBER 14, 2023

Hemgenix first drug to clear France’s ‘direct access’ route Phil.

111

111

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

MedCity News

DECEMBER 14, 2023

Through a new partnership, Talkiatry patients who need more intensive care will be able to step up to treatment with Charlie Health. Then Charlie Health patients who no longer require intensive care can step down to Talkiatry to receive ongoing psychiatric care.

Patients 111

Patients 111

pharmaphorum

DECEMBER 14, 2023

FDA starts speedy review of Amgen’s lung cancer BiTE therapy Phil.

FDA 111

FDA 111

MedCity News

DECEMBER 14, 2023

Twin Health raked in $50 million in Series D financing. The startup seeks to help patients improve their metabolic health and reduce the need for medications through the “digital twin” technology it sells to employers and health plans.

Medical 111

Medical Patients 111

PM360

DECEMBER 14, 2023

Survey any physician if they’ve been asked by a patient about a prescription weight loss medication and you’ll hear a resounding “yes.” The recent Sermo Barometer confirms that 89% of 300+ global practitioners have seen an increase in patients proactively requesting prescription weight loss medications. 1 I predict this number will only steadily increase.

Medical 105

Medical Side effects Physicians Prescription 105

Advertisement

pharmaphorum

DECEMBER 14, 2023

Twin Health raises $50m, and other digital health financings Phil.

105

105

PharmExec

DECEMBER 14, 2023

In-depth study outlines the top five reasons biopharma products miss launch forecasts.

Biopharma 105

Biopharma 105

pharmaphorum

DECEMBER 14, 2023

MindMed says LSD-based therapy effective in anxiety Phil.

105

105

PharmExec

DECEMBER 14, 2023

A discussion of the current standard for diabetes care and how the importance of patient centricity, including addressing patient's mental health, are imperative to the future of the space.

Patients 105

Patients 105

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Commerce

DECEMBER 14, 2023

Partner for Archbow Consulting discusses the conference, the IRA, and specifics of PAP business rules

Consulting 105

Consulting 105

PharmExec

DECEMBER 14, 2023

JAMA Network study evaluates current attitudes toward individuals with acne with a call for pharma companies to focus efforts on helping to overcome these stigmas.

Pharma 105

Pharma Networking 105

Pharmaceutical Commerce

DECEMBER 14, 2023

Bill Trombetta, PhD, discusses successfully navigating what he calls “the coming perfect storm” in healthcare.

Healthcare 104

Healthcare Healthcare 104

European Pharmaceutical Review

DECEMBER 14, 2023

In collaboration with Novo Nordisk, a research group from Denmark’s Aarhus University have devised a method to simplify the construction of an entire library of therapeutic oligonucleotide-peptide conjugates. Specifically, the researchers discovered a synthesis method for oligonucleotide (ON) conjugates that incorporates built-in handles and a special linker, enabling easy linkage of ONs to a peptide marker by adjusting the pH.

Specialization 103

Specialization Pharmaceutical Medicine 103

Advertisement

Distribution

PM360

DECEMBER 14, 2023

Empowering patients with comprehensive information about their health and medical conditions is a critical step towards fostering their active involvement in healthcare decisions. By equipping them with knowledge, patients can make more informed choices and collaborate effectively with healthcare providers (HCPs), ultimately enhancing the quality of care they receive.

Education 98

Education Patients Digital Media Pharma 98

PharmaVoice

DECEMBER 14, 2023

Genentech’s chief diversity officer Quita Highsmith is on a crusade to prove that much of what the industry believes about clinical trial diversity is wrong.

97

97

Pharmaceutical Technology

DECEMBER 14, 2023

Acadia received two patent rulings that strengthen Nuplazid’s patent position and protect the drug into 2038.

69

69

PM360

DECEMBER 14, 2023

NEW YORK, NY, December, 14 2023: The life sciences industry is built on innovation. From developing ground-breaking new medicines to implementing better ways to ensure patients can access and stay on therapy to experimenting with new technology that changes how care is delivered—innovation is at the heart of everything this industry does. For 12 years, PM360 , a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has re

Marketing 64

Marketing Insurance Healthcare Healthcare 64

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales